VEGFA and hypertensive disorder: Inhibition of angiogenesis with anti-VEGF antibodies or inhibition of the VEGF receptor in cancer patients can induce hypertension or lead to an increase in preexisting hypertension (Sandler et al., 2004; Holden et al., 2005).